Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Carisma Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11122
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide human macrophages the capability to identify relevant targets and induce macrophage phagocytosis and antigen-presenting functions to exterminate cancer cells in solid tumors. The company’s technology harnesses the latest developments in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy to treat multiple diseases in humans. Scientists at the University of Pennsylvania developed the CAR-macrophage platform. Carisma Therapeutics is headquartered in Philadelphia, Pennsylvania, the US.

Carisma Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carisma Therapeutics Raises USD53 Million in Series A Financing 10
CARMA Therapeutics Raises Fund through Venture Financing 12
Carisma Therapeutics Raises USD2.35 Million through Debt Offering 13
Carisma Therapeutics Inc – Key Competitors 14
Carisma Therapeutics Inc – Key Employees 15
Carisma Therapeutics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carisma Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carisma Therapeutics Raises USD53 Million in Series A Financing 10
CARMA Therapeutics Raises Fund through Venture Financing 12
Carisma Therapeutics Raises USD2.35 Million through Debt Offering 13
Carisma Therapeutics Inc, Key Competitors 14
Carisma Therapeutics Inc, Key Employees 15

List of Figures
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carisma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scienion AG-医療機器分野:企業M&A・提携分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Intelligent InSites Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intelligent InSites Inc (Insites) is a provider of real-time operational intelligence for the health care industry. The company offers implementation, training, technical support, product maintenance and solution services. Its solutions include additional end-user training, additional integr …
  • Carmell Therapeutics Corp:製品パイプライン分析
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for tot …
  • Emisphere Technologies Inc (EMIS)-製薬・医療分野:企業M&A・提携分析
    Summary Emisphere Technologies Inc (Emisphere) is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable bio-pharmaceutical products, besides new chemical entities, using its Eligen …
  • Eco (Atlantic) Oil & Gas Ltd (EOG):企業の財務・戦略的SWOT分析
    Summary Eco (Atlantic) Oil & Gas Ltd (Eco) is an oil and gas exploration and development company. The company’s business activities include acquisition, identification, and development of upstream petroleum projects across Africa. The company's projects include cooper license-PEL 030, Sharon license …
  • Saudi Electricity Co (5110):企業の財務・戦略的SWOT分析
    Saudi Electricity Co (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Penn National Gaming Inc:企業の戦略・SWOT・財務分析
    Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report Summary Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Perfint Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Perfint Healthcare Pvt Ltd (Perfint), formerly Perfint Engineering Services Pvt Ltd is a medical device company that develops image guided interventional products for onchology and pain care. The company’s products comprise MAXIO, stereotactic accessory to a computed tomography system; ROBIO …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • UCB SA (UCB):医療機器:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • AECOM (ACM):石油・ガス:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …
  • EnerMech Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary EnerMech Ltd (EnerMech) is a provider of oilfield services. The company offers cranes and lifting services, hydraulic products and services, pipeline and umbilicals services, valve services, equipment rental, training services and industrial services. Its pipeline and umbilical services comp …
  • Teekay Offshore Partners L.P.:企業のM&A・事業提携・投資動向
    Teekay Offshore Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teekay Offshore Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferring Pharmaceuticals Inc (Ferring), a subsidiary of Ferring International Center SA is a biopharmaceutical company that conducts research and development services. The company develops peptide-based drugs and biotechnology derived medicines. It also develops effective and patient-friendly …
  • Osprey Medical Inc (OSP):企業の財務・戦略的SWOT分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Electricite de France SA:発電所・企業SWOT分析
    Electricite de France SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Heartland Consumers Power District:企業の戦略的SWOT分析
    Heartland Consumers Power District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Pernix Therapeutics Holdings Inc (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Sangoma Technologies Corp (STC):企業の財務・戦略的SWOT分析
    Sangoma Technologies Corp (STC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Eskom Uganda Ltd:企業の戦略的SWOT分析
    Eskom Uganda Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆